Atlas Trials

STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease

Clinical trial NCT07280585 · RECRUITING

Trial details

NCT number
NCT07280585
Sponsor
University of Cologne
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Polycystic Kidney, Autosomal Dominant
Start date
2025-12-16
Primary completion
2030-05-15
Enrollment
420

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.